The presence of GT198+ pericytes provides a rationale for the integration of existing hypotheses in tumor angiogenesis, and implies the potential of oncoprotein GT198 as a new target in anti-angiogenesis therapy. This evidence concerns the gene PSMC3IP and neoplasm.